Personalization of loco-regional care for primary breast cancer patients (part 2)

Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter Von Minckwitz, John Fr Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis Wc Chow, Chiun Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun Sook Lee & 8 others Alexey A. Larionov, Jose Lb Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, Vicki Klimberg

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The loco-regional management of breast cancer is increasingly complex with application of primary systemic therapies, oncoplastic techniques and genetic testing for breast cancer susceptibility. Personalization of loco-regional treatment is integral to optimization of breast cancer care. Clinical and pathological tumor stage, biological features and host factors influence loco-regional treatment strategies and extent of surgical procedures. Key issues including axillary staging, axillary treatment, radiation therapy, primary systemic therapy (PST), preoperative hormonal therapy and genetic predisposition were identified and discussed at the Kyoto Breast Cancer Consensus Conference (KBCCC2014). In the second of a two part conference scene, consensus recommendations for radiation treatment, primary systemic therapies and management of genetic predisposition are reported and focus on the following topics: influence of both clinical response to PST and stage at presentation on recommendations for postmastectomy radiotherapy; use of regional nodal irradiation in selected node-positive patients and those with adverse pathological factors; extent of surgical resection following downstaging of tumors with PST; use of preoperative hormonal therapy in premenopausal women with larger, node-negative luminal A-like tumors and managing increasing demands for contralateral prophylactic mastectomy in patients with a unilateral sporadic breast cancer.

Original languageEnglish (US)
Pages (from-to)1301-1305
Number of pages5
JournalFuture Oncology
Volume11
Issue number9
DOIs
StatePublished - May 1 2015
Externally publishedYes

Fingerprint

Primary Health Care
Breast Neoplasms
Therapeutics
Genetic Predisposition to Disease
Radiotherapy
Neoplasms
Genetic Testing
Radiation

Keywords

  • BRCA1/2
  • breast cancer
  • luminal type
  • postmastectomy radiation therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Toi, M., Winer, E. P., Benson, J. R., Inamoto, T., Forbes, J. F., Von Minckwitz, G., ... Klimberg, V. (2015). Personalization of loco-regional care for primary breast cancer patients (part 2). Future Oncology, 11(9), 1301-1305. https://doi.org/10.2217/fon.15.66

Personalization of loco-regional care for primary breast cancer patients (part 2). / Toi, Masakazu; Winer, Eric P.; Benson, John R.; Inamoto, Takashi; Forbes, John F.; Von Minckwitz, Gunter; Robertson, John Fr; Grobmyer, Stephen R.; Jatoi, Ismail; Sasano, Hironobu; Kunkler, Ian; Ho, Alice Y.; Yamauchi, Chikako; Chow, Louis Wc; Huang, Chiun Sheng; Han, Wonshik; Noguchi, Shinzaburo; Pegram, Mark D.; Yamauchi, Hideko; Lee, Eun Sook; Larionov, Alexey A.; Bevilacqua, Jose Lb; Yoshimura, Michio; Sugie, Tomoharu; Yamauchi, Akira; Krop, Ian E.; Noh, Dong Young; Klimberg, Vicki.

In: Future Oncology, Vol. 11, No. 9, 01.05.2015, p. 1301-1305.

Research output: Contribution to journalArticle

Toi, M, Winer, EP, Benson, JR, Inamoto, T, Forbes, JF, Von Minckwitz, G, Robertson, JF, Grobmyer, SR, Jatoi, I, Sasano, H, Kunkler, I, Ho, AY, Yamauchi, C, Chow, LW, Huang, CS, Han, W, Noguchi, S, Pegram, MD, Yamauchi, H, Lee, ES, Larionov, AA, Bevilacqua, JL, Yoshimura, M, Sugie, T, Yamauchi, A, Krop, IE, Noh, DY & Klimberg, V 2015, 'Personalization of loco-regional care for primary breast cancer patients (part 2)', Future Oncology, vol. 11, no. 9, pp. 1301-1305. https://doi.org/10.2217/fon.15.66
Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, Von Minckwitz G et al. Personalization of loco-regional care for primary breast cancer patients (part 2). Future Oncology. 2015 May 1;11(9):1301-1305. https://doi.org/10.2217/fon.15.66
Toi, Masakazu ; Winer, Eric P. ; Benson, John R. ; Inamoto, Takashi ; Forbes, John F. ; Von Minckwitz, Gunter ; Robertson, John Fr ; Grobmyer, Stephen R. ; Jatoi, Ismail ; Sasano, Hironobu ; Kunkler, Ian ; Ho, Alice Y. ; Yamauchi, Chikako ; Chow, Louis Wc ; Huang, Chiun Sheng ; Han, Wonshik ; Noguchi, Shinzaburo ; Pegram, Mark D. ; Yamauchi, Hideko ; Lee, Eun Sook ; Larionov, Alexey A. ; Bevilacqua, Jose Lb ; Yoshimura, Michio ; Sugie, Tomoharu ; Yamauchi, Akira ; Krop, Ian E. ; Noh, Dong Young ; Klimberg, Vicki. / Personalization of loco-regional care for primary breast cancer patients (part 2). In: Future Oncology. 2015 ; Vol. 11, No. 9. pp. 1301-1305.
@article{6d73f5fa0e344143832a5e63f117c5f4,
title = "Personalization of loco-regional care for primary breast cancer patients (part 2)",
abstract = "The loco-regional management of breast cancer is increasingly complex with application of primary systemic therapies, oncoplastic techniques and genetic testing for breast cancer susceptibility. Personalization of loco-regional treatment is integral to optimization of breast cancer care. Clinical and pathological tumor stage, biological features and host factors influence loco-regional treatment strategies and extent of surgical procedures. Key issues including axillary staging, axillary treatment, radiation therapy, primary systemic therapy (PST), preoperative hormonal therapy and genetic predisposition were identified and discussed at the Kyoto Breast Cancer Consensus Conference (KBCCC2014). In the second of a two part conference scene, consensus recommendations for radiation treatment, primary systemic therapies and management of genetic predisposition are reported and focus on the following topics: influence of both clinical response to PST and stage at presentation on recommendations for postmastectomy radiotherapy; use of regional nodal irradiation in selected node-positive patients and those with adverse pathological factors; extent of surgical resection following downstaging of tumors with PST; use of preoperative hormonal therapy in premenopausal women with larger, node-negative luminal A-like tumors and managing increasing demands for contralateral prophylactic mastectomy in patients with a unilateral sporadic breast cancer.",
keywords = "BRCA1/2, breast cancer, luminal type, postmastectomy radiation therapy",
author = "Masakazu Toi and Winer, {Eric P.} and Benson, {John R.} and Takashi Inamoto and Forbes, {John F.} and {Von Minckwitz}, Gunter and Robertson, {John Fr} and Grobmyer, {Stephen R.} and Ismail Jatoi and Hironobu Sasano and Ian Kunkler and Ho, {Alice Y.} and Chikako Yamauchi and Chow, {Louis Wc} and Huang, {Chiun Sheng} and Wonshik Han and Shinzaburo Noguchi and Pegram, {Mark D.} and Hideko Yamauchi and Lee, {Eun Sook} and Larionov, {Alexey A.} and Bevilacqua, {Jose Lb} and Michio Yoshimura and Tomoharu Sugie and Akira Yamauchi and Krop, {Ian E.} and Noh, {Dong Young} and Vicki Klimberg",
year = "2015",
month = "5",
day = "1",
doi = "10.2217/fon.15.66",
language = "English (US)",
volume = "11",
pages = "1301--1305",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "9",

}

TY - JOUR

T1 - Personalization of loco-regional care for primary breast cancer patients (part 2)

AU - Toi, Masakazu

AU - Winer, Eric P.

AU - Benson, John R.

AU - Inamoto, Takashi

AU - Forbes, John F.

AU - Von Minckwitz, Gunter

AU - Robertson, John Fr

AU - Grobmyer, Stephen R.

AU - Jatoi, Ismail

AU - Sasano, Hironobu

AU - Kunkler, Ian

AU - Ho, Alice Y.

AU - Yamauchi, Chikako

AU - Chow, Louis Wc

AU - Huang, Chiun Sheng

AU - Han, Wonshik

AU - Noguchi, Shinzaburo

AU - Pegram, Mark D.

AU - Yamauchi, Hideko

AU - Lee, Eun Sook

AU - Larionov, Alexey A.

AU - Bevilacqua, Jose Lb

AU - Yoshimura, Michio

AU - Sugie, Tomoharu

AU - Yamauchi, Akira

AU - Krop, Ian E.

AU - Noh, Dong Young

AU - Klimberg, Vicki

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The loco-regional management of breast cancer is increasingly complex with application of primary systemic therapies, oncoplastic techniques and genetic testing for breast cancer susceptibility. Personalization of loco-regional treatment is integral to optimization of breast cancer care. Clinical and pathological tumor stage, biological features and host factors influence loco-regional treatment strategies and extent of surgical procedures. Key issues including axillary staging, axillary treatment, radiation therapy, primary systemic therapy (PST), preoperative hormonal therapy and genetic predisposition were identified and discussed at the Kyoto Breast Cancer Consensus Conference (KBCCC2014). In the second of a two part conference scene, consensus recommendations for radiation treatment, primary systemic therapies and management of genetic predisposition are reported and focus on the following topics: influence of both clinical response to PST and stage at presentation on recommendations for postmastectomy radiotherapy; use of regional nodal irradiation in selected node-positive patients and those with adverse pathological factors; extent of surgical resection following downstaging of tumors with PST; use of preoperative hormonal therapy in premenopausal women with larger, node-negative luminal A-like tumors and managing increasing demands for contralateral prophylactic mastectomy in patients with a unilateral sporadic breast cancer.

AB - The loco-regional management of breast cancer is increasingly complex with application of primary systemic therapies, oncoplastic techniques and genetic testing for breast cancer susceptibility. Personalization of loco-regional treatment is integral to optimization of breast cancer care. Clinical and pathological tumor stage, biological features and host factors influence loco-regional treatment strategies and extent of surgical procedures. Key issues including axillary staging, axillary treatment, radiation therapy, primary systemic therapy (PST), preoperative hormonal therapy and genetic predisposition were identified and discussed at the Kyoto Breast Cancer Consensus Conference (KBCCC2014). In the second of a two part conference scene, consensus recommendations for radiation treatment, primary systemic therapies and management of genetic predisposition are reported and focus on the following topics: influence of both clinical response to PST and stage at presentation on recommendations for postmastectomy radiotherapy; use of regional nodal irradiation in selected node-positive patients and those with adverse pathological factors; extent of surgical resection following downstaging of tumors with PST; use of preoperative hormonal therapy in premenopausal women with larger, node-negative luminal A-like tumors and managing increasing demands for contralateral prophylactic mastectomy in patients with a unilateral sporadic breast cancer.

KW - BRCA1/2

KW - breast cancer

KW - luminal type

KW - postmastectomy radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84929231264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929231264&partnerID=8YFLogxK

U2 - 10.2217/fon.15.66

DO - 10.2217/fon.15.66

M3 - Article

VL - 11

SP - 1301

EP - 1305

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 9

ER -